Review
Open access
Sep 2026
Exploring type 2 inflammation and disease complexity: perspectives of a clinical immunologist
Type 2 inflammatory diseases are often grouped together as a single immunological entity, driven by shared cytokines and overlapping pathways. This framework has led to the development of biologic therapies targeting upstream epithelial-derived “alarmins”, including thymic stromal lymphopoietin (TSLP), interleukin (IL)...
Y. Tal, Limor Rubin, A. Munitz et al.
· Frontiers in Immunology · 0 citations